Rockwell Medical

+$0.13 (+9.56%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RMTI and other ETFs, options, and stocks.

About RMTI

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte.

CEO

Russell H. Ellison

Employees

300

Headquarters

Wixom, Michigan

Founded

1995

RMTI Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

63.64K

High today

$1.70

Low today

$1.29

Open price

$1.29

Volume

199.30K

52 Week high

$10.78

52 Week low

$1.25

RMTI News

BenzingaJun 23

Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate

Last week, Rockwell Medical Inc (NASDAQ: RMTI) closed the second $7.5 million tranche of the previously announced DaVita Inc (NYSE: DVA) stock purchase agreemen

RMTI Earnings

-$1.10

-$0.73

-$0.37

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 15, After Hours

Why Robinhood?

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. View more

Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte.